FindTrial
Sign In

Effect of USG guided axillary plexus block with 0.5% Ropivacaine and intravenous Dexmedetomidine with or without intravenous dexamethasone.

Role of intravenous Dexamethasone to improve the characteristics of USG guided axillary plexus block with 0.5% Ropivacaine along with intravenous Dexmedetomidine : A prospective comparative double blind study. - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/054424
Enrollment
68
Registered
2023-06-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: USG guided axillary plexus block with ropivacaine, intravenous dexmedetomidine and intravenous dexamethasone: Ultrasound guided axillary plexus block given using 5cm PNS needle with 0

Sponsors

BARC Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients (Age >18 years) of ASA Class I, II, III undergoing forearm and hand surgery under ultrasound guided axillary plexus block and willing to participate in the study.

Exclusion criteria

Exclusion criteria: Patient refusal Local skin infection at block site Patients with difficulty to express pain scores Pregnant patients. Patient who had undergone Modified radical mastectomy with axillary LN dissection Patients on beta blockers Patients with base line HR Patients with conduction block Allergy to ropivacaine

Design outcomes

Primary

MeasureTime frame
Onset & duration of sensory & motor blockTimepoint: Immediately after the block for thirty mins—

Secondary

MeasureTime frame
Post operative analgesia Intra operative sedationTimepoint: postoperatively till the action of block receded—

Countries

India

Contacts

Public ContactRadhika Raj M R

Full time consultant Bhaba atomic research centre

priteehb@barc.gov.in9820669549

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026